| For: | Xu Z, Pothula SP, Wilson JS, Apte MV. Pancreatic cancer and its stroma: A conspiracy theory. World J Gastroenterol 2014; 20(32): 11216-11229 [PMID: 25170206 DOI: 10.3748/wjg.v20.i32.11216] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11216.htm |
| Number | Citing Articles |
| 1 |
Hayne Song, Jinhoi Song, Yeon Jeong Kim, Hyeon Hee Jeong, Hye Jin Min, Sang Seok Koh. DCPP1 is the mouse ortholog of human PAUF that possesses functional analogy in pancreatic cancer. Biochemical and Biophysical Research Communications 2017; 493(4) doi: 10.1016/j.bbrc.2017.10.015
|
| 2 |
Quan-Wang Li, Long-Fei Ma, Chuan-Bo Liu, Jie Zhou, Bin-Ya Ma, Yao-Xue Zhuang, Ke-Rui Zhang, Zhaoqi Dong. Cinobufacini Inhibits the Development of Pancreatic Cancer Cells through the TGFβ/Smads Pathway of Pancreatic Stellate Cells. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/3719857
|
| 3 |
D. A. Gnatenko, E. P. Kopantsev, E. D. Sverdlov. The role of the signaling pathway FGF/FGFR in pancreatic cancer. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2017; 11(2) doi: 10.1134/S1990750817020032
|
| 4 |
Jacek Kabut, Małgorzata Stopyra, Natalia Nafalska, Grzegorz J. Stępień, Michał Miciak, Marcin Jezierzański, Tomasz Furgoł, Krzysztof Feret, Iwona Gisterek-Grocholska. mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)—A Promising Avenue in Cancer Immunotherapy. International Journal of Molecular Sciences 2025; 26(22) doi: 10.3390/ijms262210988
|
| 5 |
Keiichi Yonemori, Naohiko Seki, Hiroshi Kurahara, Yusaku Osako, Tetsuya Idichi, Takayuki Arai, Keiichi Koshizuka, Yoshiaki Kita, Kosei Maemura, Shoji Natsugoe. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA‐375 in pancreatic ductal adenocarcinoma. Cancer Science 2017; 108(1) doi: 10.1111/cas.13119
|
| 6 |
Yuanke Li, Zhen Zhao, Hao Liu, John Peter Fetse, Akshay Jain, Chien-Yu Lin, Kun Cheng. Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma. ACS Applied Materials & Interfaces 2019; 11(49) doi: 10.1021/acsami.9b15116
|
| 7 |
Huimin Huang, Wangxiao Zhou, Renpin Chen, Bingfeng Xiang, Shipeng Zhou, Linhua Lan. CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.611508
|
| 8 |
Tianjiao Li, Hao Li, Shuo Li, Shuaishuai Xu, Wuhu Zhang, Heli Gao, Huaxiang Xu, Chuntao Wu, Wenquan Wang, Xianjun Yu, Liang Liu. Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma. Cancer Medicine 2019; 8(11) doi: 10.1002/cam4.2430
|
| 9 |
Pratibha Malhotra, Ranjith Palanisamy, Marco Falasca. Targeting pancreatic ductal adenocarcinoma: New therapeutic options for the ongoing battle. Hepatobiliary & Pancreatic Diseases International 2022; 21(1) doi: 10.1016/j.hbpd.2021.09.004
|
| 10 |
Yuanyuan Pei, Liang Chen, Yukun Huang, Jiahao Wang, Jingxian Feng, Minjun Xu, Yu Chen, Qingxiang Song, Gan Jiang, Xiao Gu, Qian Zhang, Xiaoling Gao, Jun Chen. Sequential Targeting TGF‐β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. Small 2019; 15(24) doi: 10.1002/smll.201900631
|
| 11 |
Sulagna Banerjee, Shrey Modi, Olivia McGinn, Xianda Zhao, Vikas Dudeja, Sundaram Ramakrishnan, Ashok K. Saluja. Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer. Clinical Cancer Research 2016; 22(2) doi: 10.1158/1078-0432.CCR-15-1155
|
| 12 |
Christian Philipp Reinert, Karolin Baumgartner, Tobias Hepp, Michael Bitzer, Marius Horger. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase. Abdominal Radiology 2020; 45(3) doi: 10.1007/s00261-020-02406-9
|
| 13 |
Shigeo Koido, Masato Okamoto, Shigetaka Shimodaira, Haruo Sugiyama. Wilms’ Tumor 1 (WT1)-Targeted Cancer Vaccines To Extend Survival for Patients with Pancreatic Cancer. Immunotherapy 2016; 8(11) doi: 10.2217/imt-2016-0031
|
| 14 |
Tetsuya Idichi, Naohiko Seki, Hiroshi Kurahara, Keiichi Yonemori, Yusaku Osako, Takayuki Arai, Atsushi Okato, Yoshiaki Kita, Takaaki Arigami, Yuko Mataki, Yuko Kijima, Kosei Maemura, Shoji Natsugoe. Regulation of actin-binding protein ANLN by antitumormiR-217inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma. Oncotarget 2017; 8(32) doi: 10.18632/oncotarget.18261
|
| 15 |
Zheng Li, Xiao-Jie Zhang, Chong-Yuan Sun, Ze-Feng Li, He Fei, Dong-Bing Zhao. Dissimilar survival and clinicopathological characteristics of mucinous adenocarcinoma located in pancreatic head and body/tail. World Journal of Gastrointestinal Surgery 2023; 15(6): 1178-1190 doi: 10.4240/wjgs.v15.i6.1178
Abstract(1138) |
Core Tip(1152) |
Full Article(HTML)(2121)
|
Full Article (PDF)-2286K(234)
|
Full Article with Cover (PDF)-2695K(213)
|
Full Article (Word)-1810K(115)
|
Full Article (XML)-103K(184)
|
Audio-113K(12)
|
Peer-Review Report-131K(147)
|
Answering Reviewers-240K(173)
|
Times Cited (2)
|
Total Visits (3972)
|
Open
|
| 16 |
Aarthi Gopinathan, Jennifer P. Morton, Duncan I. Jodrell, Owen J. Sansom. GEMMs as preclinical models for testing pancreatic cancer therapies. Disease Models & Mechanisms 2015; 8(10) doi: 10.1242/dmm.021055
|
| 17 |
Aleksandra Adamska, Alice Domenichini, Emily Capone, Verena Damiani, Begum Gokcen Akkaya, Kenneth J. Linton, Pierluigi Di Sebastiano, Xi Chen, Adam B. Keeton, Veronica Ramirez-Alcantara, Yulia Maxuitenko, Gary A. Piazza, Vincenzo De Laurenzi, Gianluca Sala, Marco Falasca. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1308-7
|
| 18 |
Kunlong Duan, Huihui Zhou, Wanni Xu, Li Yang, Dong Fan, Zhilin Zhang, Jun Zhang, Ming Yu. Evaluation of Tumor Fibrosis in Pancreatic Ductal Adenocarcinoma by 2-D Shear Wave Elastography: A Pilot Study. Ultrasound in Medicine & Biology 2023; 49(9) doi: 10.1016/j.ultrasmedbio.2023.06.003
|
| 19 |
Chung-Tzu Hsueh, Julie H Selim, James Y Tsai, Chung-Tsen Hsueh. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. World Journal of Gastroenterology 2016; 22(31): 7080-7090 doi: 10.3748/wjg.v22.i31.7080
|
| 20 |
Ryo Takaji, Yasunari Yamada, Shunro Matsumoto, Maki Kiyonaga, Norio Hongo, Hiromu Mori, Naoki Hijiya, Masayuki Ohta, Masafumi Inomata, Hajime Takaki, Kengo Fukuzawa, Hirotoshi Yonemasu. Small pancreatic ductal carcinomas on triple-phase contrast-enhanced computed tomography: enhanced rims and the pathologic correlation. Abdominal Radiology 2018; 43(12) doi: 10.1007/s00261-018-1645-6
|
| 21 |
Aleksandra Adamska, Alice Domenichini, Marco Falasca. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. International Journal of Molecular Sciences 2017; 18(7) doi: 10.3390/ijms18071338
|
| 22 |
Archana Bhaw-Luximon, Dhanjay Jhurry. New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug delivery. Cancer Letters 2015; 369(2) doi: 10.1016/j.canlet.2015.09.007
|
| 23 |
Lena Abu-El-Haija, Julie S. Ivy, Osman Ozaltin, Walter Park. The Effect of the Distribution of the Inverse Growth Rate on Pancreatic Cancer Progression. 2019 Winter Simulation Conference (WSC) 2019; doi: 10.1109/WSC40007.2019.9004877
|
| 24 |
Qiang Ma, Huanwen Wu, Ying Xiao, Zhiyong Liang, Tonghua Liu. Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity. International Journal of Oncology 2020; doi: 10.3892/ijo.2020.4986
|
| 25 |
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico, Ahmed M. Elamir. Pancreatic Cancer. 2018; doi: 10.1007/978-1-4939-6631-8_89-1
|
| 26 |
Pedro Enrique Guerrero, Adrià Duran, Maria Rosa Ortiz, Ernesto Castro, Adelaida Garcia-Velasco, Esther Llop, Rosa Peracaula. Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLex) in pancreatic adenocarcinoma. Journal of Proteomics 2021; 231 doi: 10.1016/j.jprot.2020.104004
|
| 27 |
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico, Ahmed M. Elamir. Pancreatic Cancer. 2018; doi: 10.1007/978-1-4939-7193-0_89
|
| 28 |
Stefano Coppola, Ilaria Carnevale, Erik H.J. Danen, Godefridus J. Peters, Thomas Schmidt, Yehuda G. Assaraf, Elisa Giovannetti. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer. Drug Resistance Updates 2017; 31 doi: 10.1016/j.drup.2017.07.001
|
| 29 |
. 2015; doi: 10.70675/c64d29e3zd325z429dz9ccaza12501af896d
|
| 30 |
Joni Leppänen, Ville Lindholm, Joel Isohookana, Kirsi-Maria Haapasaari, Peeter Karihtala, Petri P. Lehenkari, Juha Saarnio, Joonas H. Kauppila, Tuomo J. Karttunen, Olli Helminen, Heikki Huhta. Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. Pancreas 2019; 48(1) doi: 10.1097/MPA.0000000000001195
|
| 31 |
Matias Estaras, Antonio Gonzalez. Modulation of cell physiology under hypoxia in pancreatic cancer. World Journal of Gastroenterology 2021; 27(28): 4582-4602 doi: 10.3748/wjg.v27.i28.4582
|
| 32 |
Xiaohong Li, Ying Xiao, Shaoqing Fan, Mingbing Xiao, Xiaotong Wang, Xiaolin Zhu, Xudong Chen, Chunsun Li, Guijuan Zong, Guoxiong Zhou, Chunhua Wan. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma. Human Pathology 2016; 57 doi: 10.1016/j.humpath.2016.07.015
|
| 33 |
Zhihong Xu, Tony C. Y. Pang, Adele C. Liu, Srinivasa P. Pothula, Alpha Raj Mekapogu, Chamini J. Perera, Takashi Murakami, David Goldstein, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte. Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis. British Journal of Cancer 2020; 122(10) doi: 10.1038/s41416-020-0782-1
|
| 34 |
V. Taucher, Johannes Haybaeck. Mechanisms of Molecular Carcinogenesis – Volume 2. 2017; doi: 10.1007/978-3-319-53661-3_5
|
| 35 |
Shin Il Kim, Jun Young Shin, Jin-Seok Park, Seok Jeong, Yong Sun Jeon, Moon Han Choi, Hyun Jong Choi, Jong Ho Moon, Jae Chul Hwang, Min Jae Yang, Byoung Moo Yoo, Jin Hong Kim, Hyun Woo Lee, Chang-Il Kwon, Don Haeng Lee. Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancer. Pancreatology 2017; 17(1) doi: 10.1016/j.pan.2016.10.008
|
| 36 |
Molecular Processes Involved in Pancreatic Cancer and Therapeutics. Current Chemical Biology 2021; 15(1) doi: 10.2174/2212796814999201008130819
|
| 37 |
Valerio Falasca, Marco Falasca. Targeting the Endocannabinoidome in Pancreatic Cancer. Biomolecules 2022; 12(2) doi: 10.3390/biom12020320
|
| 38 |
. 2021; doi: 10.70675/264bf0e9z97a7z4aaezaf51z5387f0dd8f4c
|
| 39 |
B. Čunderlíková. Clinical significance of immunohistochemically detected extracellular matrix proteins and their spatial distribution in primary cancer. Critical Reviews in Oncology/Hematology 2016; 105 doi: 10.1016/j.critrevonc.2016.04.017
|
| 40 |
Hendrik Ungefroren, Julissa Reimann, Björn Konukiewitz, Rüdiger Braun, Ulrich F. Wellner, Hendrik Lehnert, Jens-Uwe Marquardt. RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer. Biomedicines 2024; 12(1) doi: 10.3390/biomedicines12010199
|
| 41 |
Sophie Liot, Jonathan Balas, Alexandre Aubert, Laura Prigent, Perrine Mercier-Gouy, Bernard Verrier, Philippe Bertolino, Ana Hennino, Ulrich Valcourt, Elise Lambert. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.612271
|
| 42 |
A K Thakur, J Nigri, S Lac, J Leca, C Bressy, P Berthezene, L Bartholin, P Chan, E Calvo, J L Iovanna, S Vasseur, F Guillaumond, R Tomasini. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death & Differentiation 2016; 23(8) doi: 10.1038/cdd.2016.18
|
| 43 |
Zibo Meng, Dianyun Ren, Kun Zhang, Jingyuan Zhao, Xin Jin, Heshui Wu. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma. Aging 2020; 12(6) doi: 10.18632/aging.102931
|
| 44 |
Simone Kumstel, Tim Schreiber, Lea Goldstein, Jan Stenzel, Tobias Lindner, Markus Joksch, Xianbin Zhang, Edgar Heinz Uwe Wendt, Maria Schönrogge, Bernd Krause, Brigitte Vollmar, Dietmar Zechner, Irina V. Balalaeva. Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. PLOS ONE 2022; 17(4) doi: 10.1371/journal.pone.0266601
|
| 45 |
Shivang Dhoundiyal, Md. Aftab Alam. Overcoming the Limitations of Therapeutic Strategies to Combat Pancreatic
Cancer using Nanotechnology. Current Cancer Drug Targets 2023; 23(9) doi: 10.2174/1568009623666230329085618
|
| 46 |
Jung Hwan Lee, Sang Myung Woo, Eun Kyung Hong, Sang‐Jae Park, Sung‐Sik Han, Tae Hyun Kim, Ju Hee Lee, Woo Jin Lee. Cytopathological results of initial endoscopic ultrasound‐guided fine needle aspiration for primary mass and prognosis in pancreatic cancer patients. Cytopathology 2019; 30(2) doi: 10.1111/cyt.12675
|
| 47 |
Jaideep Chakladar, Selena Z. Kuo, Grant Castaneda, Wei Tse Li, Aditi Gnanasekar, Michael Andrew Yu, Eric Y. Chang, Xiao Qi Wang, Weg M. Ongkeko. The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers. Cancers 2020; 12(9) doi: 10.3390/cancers12092672
|
| 48 |
Srinivasa P. Pothula, Zhihong Xu, David Goldstein, Neil Merrett, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte. Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer. Oncotarget 2017; 8(44) doi: 10.18632/oncotarget.20822
|
| 49 |
Wei Zhang, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Dingbin Liu, Yuling Wang. Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01641-0
|
| 50 |
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Chiara Birtolo, Giorgia Acquaviva, Michela Visani, Adele Fornelli, Michele Masetti, Andrea Tura, Stefano Sbrignadello, Fabio Grizzi, Federica Patrinicola, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Claudia Benini, Luca Di Tommaso, Arrigo Bondi, Francesco Monetti, Elena Siopis, Paolo Emilio Orlandi, Michele Imbriani, Carlo Fabbri, Silvia Giovanelli, Andrea Domanico, Esterita Accogli, Salomone Di Saverio, Daniela Grifoni, Vincenzo Cennamo, Paolo Leandri, Elio Jovine, Dario de Biase. Matricellular proteins and survival in patients with pancreatic cancer: A systematic review. Pancreatology 2018; 18(1) doi: 10.1016/j.pan.2017.11.001
|
| 51 |
Shuo Wang, Jiang Chen, Hongyu Li, Xingshun Qi, Xu Liu, Xiaozhong Guo. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD82 Cell Line. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211045204
|
| 52 |
Magdalena Swierczewska, Serguei Kozlov, Pavan P. Adiseshaiah. Oncogenomics. 2019; doi: 10.1016/B978-0-12-811785-9.00022-3
|
| 53 |
Bing Ren, Xiaoying Liu, Arief A. Suriawinata. Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions. The American Journal of Pathology 2019; 189(1) doi: 10.1016/j.ajpath.2018.10.004
|
| 54 |
Antoine Schernberg, Dewi Vernerey, David Goldstein, Jean-Luc Van Laethem, Bengt Glimelius, Paul van Houtte, Franck Bonnetain, Christophe Louvet, Pascal Hammel, Florence Huguet. Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2021; 110(4) doi: 10.1016/j.ijrobp.2021.01.052
|
| 55 |
Anna De Blasio, Renza Vento, Riccardo Di Fiore. Mcl‐1 targeting could be an intriguing perspective to cure cancer. Journal of Cellular Physiology 2018; 233(11) doi: 10.1002/jcp.26786
|
| 56 |
Matthew Hadden, Anubhav Mittal, Jaswinder Samra, Hala Zreiqat, Sumit Sahni, Yogambha Ramaswamy. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2) doi: 10.1016/j.bbcan.2020.188418
|
| 57 |
Srinivasa P. Pothula, Zhihong Xu, David Goldstein, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte. Key role of pancreatic stellate cells in pancreatic cancer. Cancer Letters 2016; 381(1) doi: 10.1016/j.canlet.2015.10.035
|
| 58 |
Janusz Franco-Barraza, Mariia Dmitrieva, Tiffany Luong, Brian L. Egleston, Kristopher Raghavan, Jessica K. Wong, Débora Barbosa Vendramini-Costa, Ralph Francescone, Jaye C. Gardiner, Elizabeth Handorf, Aleksandr Dolskii, Sanjay S. Reddy, Joshua E. Meyer, Edna Cukierman. Pulsed Low-Dose-Rate Chemoradiation Induces Stromal Reprogramming in Pancreatic CAF-Generated ECM: Quantification by the HOST-Factor. Gastro Hep Advances 2026; 5(4) doi: 10.1016/j.gastha.2026.100902
|
| 59 |
. 2019; doi: 10.70675/674ea5daza64cz4b92z8e11zdbf9b854c481
|
| 60 |
Wenzel M. Hackeng, Ralph H. Hruban, G. Johan A. Offerhaus, Lodewijk A. A. Brosens. Surgical and molecular pathology of pancreatic neoplasms. Diagnostic Pathology 2016; 11(1) doi: 10.1186/s13000-016-0497-z
|
| 61 |
Nobutaka Ebata, Masashi Fujita, Shota Sasagawa, Kazuhiro Maejima, Yuki Okawa, Yutaka Hatanaka, Tomoko Mitsuhashi, Ayako Oosawa-Tatsuguchi, Hiroko Tanaka, Satoru Miyano, Toru Nakamura, Satoshi Hirano, Hidewaki Nakagawa. Molecular Classification and Tumor Microenvironment Characterization of Gallbladder Cancer by Comprehensive Genomic and Transcriptomic Analysis. Cancers 2021; 13(4) doi: 10.3390/cancers13040733
|
| 62 |
Sadaf Ghanaatgar-Kasbi, Shadi Khorrami, Amir Avan, Seyed A. Aledavoud, Gordon A. Ferns. Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Current Pharmaceutical Design 2019; 24(39) doi: 10.2174/1381612825666190110145855
|
| 63 |
Raja Kalayarasan, Sankar Narayanan, Jayaprakash Sahoo, Pazhanivel Mohan. Impact of surgery for chronic pancreatitis on the risk of pancreatic cancer: Untying the Gordian knot. World Journal of Gastroenterology 2021; 27(27): 4371-4382 doi: 10.3748/wjg.v27.i27.4371
|
| 64 |
Daniel Ansari, Adam Gustafsson, Roland Andersson. Update on the management of pancreatic cancer: Surgery is not enough. World Journal of Gastroenterology 2015; 21(11): 3157-3165 doi: 10.3748/wjg.v21.i11.3157
|
| 65 |
Milind Javle, Talia Golan, Anirban Maitra. Changing the course of pancreatic cancer – Focus on recent translational advances. Cancer Treatment Reviews 2016; 44 doi: 10.1016/j.ctrv.2016.01.004
|
| 66 |
Myrna Hurtado, Umesh T. Sankpal, Amalendu Ranjan, Rajasekhar Maram, Jamboor K. Vishwanatha, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes, Riyaz Basha. Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. Critical Reviews in Oncology/Hematology 2018; 126 doi: 10.1016/j.critrevonc.2018.03.016
|
| 67 |
NINO TORIA, ZURAB ZAALISHVILI, MALKHAZ MIZANDARI, TINATIN CHIKOVANI. DESTRUCTION OF TUMOR MICROENVIRONMENT AS A PROMISING TREATMENT APPROACH IN PANCREATIC CANCER. EXPERIMENTAL & CLINICAL MEDICINE GEORGIA 2022; doi: 10.52340/jecm.2022.06.05.11
|
| 68 |
James H. Monkman, Erik W. Thompson, Shivashankar H. Nagaraj. Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease. Cancers 2019; 11(11) doi: 10.3390/cancers11111745
|
| 69 |
Hye-ran Moon, Bumsoo Han. Biomaterials for Cancer Therapeutics. 2020; doi: 10.1016/B978-0-08-102983-1.00015-6
|
| 70 |
Mingzhe Li, Huahu Guo, Qi Wang, Kai Chen, Kornmann Marko, Xiaodong Tian, Yinmo Yang. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway. Cancer Letters 2020; 490 doi: 10.1016/j.canlet.2020.06.009
|
| 71 |
Melek Karaca, Rinku Dutta, Yildiz Ozsoy, Ram I. Mahato. Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer. Molecular Pharmaceutics 2016; 13(6) doi: 10.1021/acs.molpharmaceut.5b00971
|
| 72 |
Dajia Liu, Anne Steins, Remy Klaassen, Amber P. van der Zalm, Roel J. Bennink, Geertjan van Tienhoven, Marc G. Besselink, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven. Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma. Biomedicines 2020; 8(11) doi: 10.3390/biomedicines8110444
|
| 73 |
Aoife S Crawley, Richard J O’Kennedy. The need for effective pancreatic cancer detection and management: a biomarker-based strategy. Expert Review of Molecular Diagnostics 2015; 15(10) doi: 10.1586/14737159.2015.1083862
|
| 74 |
Lichao Pan, Lin Zhou, Weijia Yin, Jia Bai, Rong Liu. miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4380
|
| 75 |
Dai Hoon Han, Chang Moo Kang, Sung Whan Lee, Ho Kyoung Hwang, Woo Jung Lee. A missing link between RON expression and oncological outcomes in resected left-sided pancreatic cancer. Oncology Letters 2017; 14(4) doi: 10.3892/ol.2017.6696
|
| 76 |
Adriana G. Quiroz-Reyes, Jose F. Islas, Paulina Delgado-Gonzalez, Hector Franco-Villarreal, Elsa N. Garza-Treviño. Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma. Pharmaceutics 2021; 13(1) doi: 10.3390/pharmaceutics13010103
|
| 77 |
Craig D. Logsdon, Thiruvengadam Arumugam, Vijaya Ramachandran. Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 309(5) doi: 10.1152/ajpgi.00169.2015
|
| 78 |
Srinivasa P Pothula, Zhihong Xu, David Goldstein, Andrew V Biankin, Romano C Pirola, Jeremy S Wilson, Minoti V Apte. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer. British Journal of Cancer 2016; 114(3) doi: 10.1038/bjc.2015.478
|
| 79 |
Naofumi Mukaida, Soichiro Sasaki. Fibroblasts, an inconspicuous but essential player in colon cancer development and progression. World Journal of Gastroenterology 2016; 22(23): 5301-5316 doi: 10.3748/wjg.v22.i23.5301
|
| 80 |
Yi-Nong Yu, Shui-Quan Jin, Ye-Ting Lu, Lv-Zhou Han. Stroma-nerve axis in pancreatic ductal adenocarcinoma: Bidirectional regulatory mechanisms and clinical translation hypothesis. World Journal of Clinical Oncology 2026; 17(4): 117197 doi: 10.5306/wjco.v17.i4.117197
|
| 81 |
Laleh G. Melstrom, Marcela D. Salazar, Don J. Diamond. The pancreatic cancer microenvironment: A true double agent. Journal of Surgical Oncology 2017; 116(1) doi: 10.1002/jso.24643
|
| 82 |
Osama Al-Assar, Martin-Immanuel Bittner, Serena Lunardi, Michael R. Stratford, W. Gillies McKenna, Thomas B. Brunner. The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells. Radiotherapy and Oncology 2016; 119(2) doi: 10.1016/j.radonc.2016.03.024
|
| 83 |
Baiping An, Yi Cai, Jie Zhu, Yuan Liu, Zhijun Liao. [Retracted] Long Noncoding RNA LINC01503 Silencing Suppresses KLK4 Expression to Impede Pancreatic Cancer Development as miR‐1321 Sponge. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/5403344
|
| 84 |
Ryan Clay, Shadab A. Siddiqi. Theranostic Approach for Pancreatic Cancer. 2019; doi: 10.1016/B978-0-12-819457-7.00016-5
|
| 85 |
Kim Vaiphei. Molecular interphase between extracellular matrix & cancer cells. Indian Journal of Medical Research 2017; 146(3) doi: 10.4103/ijmr.IJMR_1601_16
|
| 86 |
Kelly J. Lafaro, Laleh G. Melstrom. The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment. The American Journal of Pathology 2019; 189(1) doi: 10.1016/j.ajpath.2018.09.009
|
| 87 |
Hendrik Ungefroren, Björn Konukiewitz, Rüdiger Braun, Ulrich Friedrich Wellner, Hendrik Lehnert, Jens-Uwe Marquardt. TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation. Cancers 2023; 15(15) doi: 10.3390/cancers15153791
|
| 88 |
Zhenfeng Tian, Guangsheng Ou, Mingxin Su, Ruomeng Li, Lele Pan, Xingyi Lin, Jinmao Zou, Shangxiang Chen, Yaqing Li, Kaihong Huang, Yinting Chen. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. Cancer Letters 2022; 546 doi: 10.1016/j.canlet.2022.215863
|
| 89 |
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. International Journal of Molecular Sciences 2022; 23(17) doi: 10.3390/ijms231710132
|
| 90 |
Marco Falasca, Minkyoung Kim, Ilaria Casari. Pancreatic cancer: Current research and future directions. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016; 1865(2) doi: 10.1016/j.bbcan.2016.01.001
|
| 91 |
Anna La Salvia, Irene Persano, Elena Parlagreco, Alessandro Audisio, Massimiliano Cani, Maria Pia Brizzi. Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon. Medical Oncology 2022; 39(11) doi: 10.1007/s12032-022-01764-2
|
| 92 |
Janaiah Kota, Julie Hancock, Jason Kwon, Murray Korc. Pancreatic cancer: Stroma and its current and emerging targeted therapies. Cancer Letters 2017; 391 doi: 10.1016/j.canlet.2016.12.035
|
| 93 |
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Lei You, Junchao Guo. Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.576399
|
| 94 |
Derek P. Logsdon, Michelle Grimard, Meihua Luo, Safi Shahda, Yanlin Jiang, Yan Tong, Zhangsheng Yu, Nicholas Zyromski, Ernestina Schipani, Fabrizio Carta, Claudiu T. Supuran, Murray Korc, Mircea Ivan, Mark R. Kelley, Melissa L. Fishel. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models. Molecular Cancer Therapeutics 2016; 15(11) doi: 10.1158/1535-7163.MCT-16-0253
|
| 95 |
Josephine Görte, Erik Danen, Nils Cordes. Therapy-Naive and Radioresistant 3-Dimensional Pancreatic Cancer Cell Cultures Are Effectively Radiosensitized by β1 Integrin Targeting. International Journal of Radiation Oncology*Biology*Physics 2022; 112(2) doi: 10.1016/j.ijrobp.2021.08.035
|
| 96 |
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu, Jiannan Li. Polymer nanoparticle-assisted chemotherapy of pancreatic cancer. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920915978
|
| 97 |
Yichen Li, Xing Wang, Yong-Hua Chen, Qing-Quan Tan, Xu-Bao Liu, Chunlu Tan. Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells. Anti-Cancer Drugs 2024; 35(3) doi: 10.1097/CAD.0000000000001561
|
| 98 |
Huan Meng, Andre E. Nel. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer. Advanced Drug Delivery Reviews 2018; 130 doi: 10.1016/j.addr.2018.06.014
|
| 99 |
Chang Liu, Jin-Ou Wang, Wen-Yang Zhou, Xiao-Ying Chang, Ming-Ming Zhang, Ying Zhang, Xiang-Hong Yang. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p. Molecular and Cellular Endocrinology 2019; 493 doi: 10.1016/j.mce.2019.04.004
|
| 100 |
Emre Basar, Henry Mead, Bennett Shum, Ingrid Rauter, Cihan Ay, Adriane Skaletz-Rorowski, Norbert H. Brockmeyer. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B. Pharmaceutics 2024; 16(9) doi: 10.3390/pharmaceutics16091207
|
| 101 |
Yang Liu, Lianfang Du. Role of pancreatic stellate cells and periostin in pancreatic cancer progression. Tumor Biology 2015; 36(5) doi: 10.1007/s13277-015-3386-2
|
| 102 |
Miriam Klau, Philipp Mayer, Frank Bergmann, Klaus Maier-Hein, Judith Hase, Thilo Hackert, Hans-Ulrich Kauczor, Lars Grenacher, Bram Stieltjes. Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion–Derived Parameters in Pancreatic Ductal Adenocarcinomas and Pancreatic Neuroendocrine Tumors. Investigative Radiology 2015; 50(11) doi: 10.1097/RLI.0000000000000187
|
| 103 |
Zipeng Lu, Maximilian Weniger, Kuirong Jiang, Stefan Boeck, Kai Zhang, Alexander Bazhin, Yi Miao, Jens Werner, Jan G. D’Haese. Therapies Targeting the Tumor Stroma and the VEGF/VEGFR Axis in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-Analysis. Targeted Oncology 2018; 13(4) doi: 10.1007/s11523-018-0578-x
|
| 104 |
Xianbin Zhang, Maria Schönrogge, Johanna Eichberg, Edgar Heinz Uwe Wendt, Simone Kumstel, Jan Stenzel, Tobias Lindner, Robert Jaster, Bernd Joachim Krause, Brigitte Vollmar, Dietmar Zechner. Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00590
|
| 105 |
Jin Long, Zhe Liu, Lian Hui. Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma. BMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2544-2
|
| 106 |
Marc Damelin. Innovations for Next-Generation Antibody-Drug Conjugates. Cancer Drug Discovery and Development 2018; doi: 10.1007/978-3-319-78154-9_1
|
| 107 |
Dan Wang, Yuqiang Li, Heming Ge, Tarik Ghadban, Matthias Reeh, Cenap Güngör. The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. Cancers 2022; 14(16) doi: 10.3390/cancers14163998
|
| 108 |
Ryo Takaji, Yasunari Yamada, Ryuichi Shimada, Shunro Matsumoto, Tsutomu Daa, Yuichi Endo, Masafumi Inomata, Yoshiki Asayama. Retrospective evaluation of venous phase contrast-enhanced computed tomography images in patients who developed pancreatic adenocarcinomas after treatment for nonpancreatic primary cancer. BJR|Open 2021; 3(1) doi: 10.1259/bjro.20200069
|